Abstract: In a driving support apparatus for a vehicle, when a driver indicates the intension to turn by turning a turn signal switch on, vehicles traveling on a lane to which the driver intends to turn is detected based on images captured by monitoring cameras, a space to cut into between the vehicles is calculated, an entry start time of a subject vehicle is obtained based on a speed difference between a speed of the subject vehicle and a moving speed of the space to cut into, and, when the entry start time is reached, voice guidance instructing to start turning is output from an instruction unit.

Abstract: In a driving support apparatus for a vehicle, when a driver indicates the intension to turn by turning a turn signal switch on, vehicles traveling on a lane to which the driver intends to turn is detected based on images captured by monitoring cameras, a space to cut into between the vehicles is calculated, an entry start time of a subject vehicle is obtained based on a speed difference between a speed of the subject vehicle and a moving speed of the space to cut into, and, when the entry start time is reached, voice guidance instructing to start turning is output from an instruction unit.

Abstract: The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water-low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to efficient and high permeability to the blood at the mucosa. The present invention further provides a pharmaceutical composition for application to the mucosa comprising a hemostatic agent and a medicament. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to permeability and retentivity at the mucosa.

Abstract: The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water-low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to efficient and high permeability to the blood at the mucosa. The present invention further provides a pharmaceutical composition for application to the mucosa comprising a hemostatic agent and a medicament. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to permeability and retentivity at the mucosa.

Abstract: The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water-low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to efficient and high permeability to the blood at the mucosa. The present invention further provides a pharmaceutical composition for application to the mucosa comprising a hemostatic agent and a medicament. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to permeability and retentivity at the mucosa.

Abstract: The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water-low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to efficient and high permeability to the blood at the mucosa. The present invention further provides a pharmaceutical composition for application to the mucosa comprising a hemostatic agent and a medicament. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to permeability and retentivity at the mucosa.

Abstract: A dynamic damper is disposed between an upper spring seat and a strut mount, comprising a supporting plate secured to a piston rod of a strut and an annular inertia mass body mounted on the supporting plate through an elastic member. The annular inertia mass body is connected at two edge portions thereof located opposite to each other across the diameter with the supporting plate by a bolt and nut through the elastic member, respectively.

Abstract: A device for administering a powdery medicine satisfying the requirements of portability, easy and quick operation, fabrication through simple steps, rigid structure, and economy using decreased number of parts of low cost.